Vinuri De Silva Biodesign Competition 2024

The competition continued to grow in 2024 with 69 participants across 13 teams and attracted participants across 6 different Australian universities. The competition fostered multidisciplinary collaboration with participants coming from 15 different degrees and areas of study. We are extremely grateful for the continued support of our Sponsors Phillips Ormonde Fitzpatrick, MedTech Actuator and Research Innovation Commercialisation.

 

2024 Winners

 

Vinuri De Silva Biodesign Award: Dyaxa

RIC Innovation Award: AlloPatch

MedTech Actuator People’s Choice Award: Ovimise

​

One of the winning teams progressed further and participated in the MedTech Actuator Origin Program. 

 

Dyaxa

2024 Vinuri De Silva Biodesign Award

Dyaxa aims to increase the adoption of VR technology in Healthcare and Education by cancelling out VR Motion Sickness, making patients and clinicians medical experience more accessible, customisable and interactive.

 

Allopatch 

2024 RIC Innovation Award

Allopatch aims to change the way that patient care is delivered by providing an alternative form of immunotherapy that is both safer and more effective, creating a happier and healthier future for Australians with allergies.

​

Ovimise 

2024 MedTech Actuator People’s Choice Award

Ovimise offers a non-invasive, continuous hormone monitoring solution designed to streamline IVF treatments - with the goal of revolutionizing fertility care.